Patients were divided according to the expression of FAM134B (high expression or non‐high expression).We then performed western blotting to measure expression of FAM134B in liver cell lines and human HCC cell lines with varying cell context and metastatic capability. Here, RETREG1 is linked to hepatocellular carcinoma.